Featured Research

from universities, journals, and other organizations

Defective signaling pathway leads to vascular malformations in the brain

Date:
June 30, 2010
Source:
Helmholtz Association of German Research Centres
Summary:
A disrupted signaling pathway in endothelial cells, which line the insides of blood vessels, leads to cavernomas, vascular malformations in the brain which are often dangerous. Researchers have found the cause of one of the most common human malformations and point out that cavernomas might be treated by drugs which inhibit vascular growth.

Human blood vessel in an experimental mouse model: Turning off the CCM1 gene leads to the typical, disorganized appearance.
Credit: German Cancer Research Center

A disrupted signaling pathway in endothelial cells, which line the insides of blood vessels, leads to cavernomas, vascular malformations in the brain which are often dangerous. This has been published by a research team of the Medical Faculty Mannheim of Heidelberg University and the German Cancer Research Center. The investigators have found the cause of one of the most common human malformations and point out that cavernomas might be treated by drugs which inhibit vascular growth.

Benign vascular malformations known as cavernomas can occur in many tissues of the body. These abnormalities are characterized by enlarged, instable and unstructured blood vessels. Cavernomas of medical relevance are primarily those of the brain, which develop approximately in one out of two hundred people. In the brain, such growths often remain unnoticed and are typically found by chance in MRI scans. If they grow larger, they often cause unspecific symptoms such as headaches or dizziness. There is a growing danger of cerebral hemorrhage from these vascular growths, which can lead to seizures, neurological failures and even stroke. Therefore, cavernomas causing symptoms are surgically removed from the brain, if possible.

In the joint department of Vascular Biology and Tumor Metastasis of Mannheim Medical Faculty of Heidelberg University and DKFZ, researchers are investigating how blood vessels and lymphatic vessels are newly formed in tumor diseases. "Our latest findings suggest that -- like in tumors -- excessive and uncontrolled vascular growth leads to the development of cavernomas," said Dr. Andreas Fischer, who leads the current study, published in the Proceedings of the National Academy of Sciences.

It was already known that the disease develops when the CCM1 gene is inactive in endothelial cells, which line all blood vessels. However, it was still unclear why this leads to the characteristic malformations. The research team has now identified, jointly with colleagues from Essen and Greifswald, the central signaling pathways in endothelial cells which are affected if the CCM1 gene is missing. For best possible simulation of the disease occurring in humans, the investigators transplanted human endothelial cells with disabled CCM1 gene into mice. The transplanted cells subsequently grew into the typical vascular malformations. Thus, it was possible to perform experiments with human vascular malformations in the mouse model. Therefore, the results obtained can well be transferred to the human disease situation so that it was even possible, for example, to perform drug tests.

In their first approach, the researchers tested the anticancer drug sorafenib, which inhibits the formation of new blood vessels (angiogenesis). In the transplanted mice, the substance led to massive reduction of the vascular growth. "We will now investigate whether we can treat brain cavernomas without surgery using a drug from cancer medicine," said Dr. Andreas Fischer describing the project's future goals.


Story Source:

The above story is based on materials provided by Helmholtz Association of German Research Centres. Note: Materials may be edited for content and length.


Journal Reference:

  1. Wόstehube J, Bartol A, Liebler SS, Brόtsch R, Zhu Y, Felbor U, Sure U, Augustin HG, Fischer A. Cerebral cavernous malformation protein CCM1 inhibits sprouting angiogenesis by activating DELTA-NOTCH signaling. Proceedings of the National Academy of Sciences, 2010; DOI: 10.1073/pnas.1000132107

Cite This Page:

Helmholtz Association of German Research Centres. "Defective signaling pathway leads to vascular malformations in the brain." ScienceDaily. ScienceDaily, 30 June 2010. <www.sciencedaily.com/releases/2010/06/100622112550.htm>.
Helmholtz Association of German Research Centres. (2010, June 30). Defective signaling pathway leads to vascular malformations in the brain. ScienceDaily. Retrieved August 27, 2014 from www.sciencedaily.com/releases/2010/06/100622112550.htm
Helmholtz Association of German Research Centres. "Defective signaling pathway leads to vascular malformations in the brain." ScienceDaily. www.sciencedaily.com/releases/2010/06/100622112550.htm (accessed August 27, 2014).

Share This




More Health & Medicine News

Wednesday, August 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Predicting Heart Transplant Rejection With a Blood Test

Predicting Heart Transplant Rejection With a Blood Test

Ivanhoe (Aug. 27, 2014) — Now a new approach to rejection of donor organs could change the way doctors predict transplant rejection…without expensive, invasive procedures. Video provided by Ivanhoe
Powered by NewsLook.com
Better Braces That Vibrate

Better Braces That Vibrate

Ivanhoe (Aug. 27, 2014) — The length of time you have to keep your braces on could be cut in half thanks to a new device that speeds up the process. Video provided by Ivanhoe
Powered by NewsLook.com
Smartphone App Tracks Your Heart Rate

Smartphone App Tracks Your Heart Rate

Ivanhoe (Aug. 27, 2014) — A new app that can track your heart rate 24/7 is available for download in your app store and its convenience could save your life. Video provided by Ivanhoe
Powered by NewsLook.com
Stroke in Young Adults

Stroke in Young Adults

Ivanhoe (Aug. 27, 2014) — A stroke can happen at any time and affect anyone regardless of age. This mother chose to give her son independence and continue to live a normal life after he had a stroke at 18 years old. Video provided by Ivanhoe
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins